EMBRYONIC DEVELOPMENT & STEM CELL COMPENDIUM
Content
All Cell Therapies > Cell Therapy Card
Sign in for full access

Hematopoietic stem cells for refractory myasthenia gravis

The aim of this study is to assess the safety and feasibility of autologous peripheral hematopoietic stem cell transplantation in patients with refractory myasthenia gravis following patient conditioning with a high dose cyclophosphamide and anti-thymocyte globulin.

In patients with low yield of peripheral blood stem cells, bone marrow was subsequently harvested.
See additional Cell Therapies for: Motor Neurons
Hematopoietic stem cells for refractory myasthenia gravis
Home
Contact Us
About Terms of Use Privacy Policy
Copyright LifeMap Sciences, Inc. - All Rights Reserved (v4.14 Build 1)
This site does not provide medical advice and is for research use only